— AngioDynamics Inc. (NASDAQ: ANGO) reported Q2 2020 earnings of $0.06 per share, vs. $0.02 expected.
— Net sales remained flat at $70 million, vs. $71.2 million expected.
— US net sales grew 1.8% to $55.6 million.
— International net sales increased 5.6% to $14.4 million.
— Oncology net sales rose 5.1% to $16.1 million.
— Vascular Interventions and Therapies net sales grew 0.6% to $31.2 million.
— Vascular Access net sales fell 4% to $22.8 million.
— FY2020 net sales are expected to be $280-286 million.
— FY2020 adjusted EPS is expected to be $0.10-0.15.
Get access to timely and accurate verbatim transcripts that are published within hours of the event.
Most Popular
Earnings calendar for the week of Oct. 19
Undoubtedly the biggest event of the week was the launch of iPhone 12, the latest in Apple's smartphone series. Pre-orders for the standard model starts Friday, while the premium version
Walgreens Boots Alliance (WBA) to invest $1 billion in omnichannel capabilities next year
Shares of Walgreens Boots Alliance (NASDAQ: WBA) have dropped 36% since the beginning of the year, and the stock remained in red on Friday. The company reported its fourth quarter
BNY Mellon (BK) Earnings: Key financials and quarterly highlights
The Bank of New York Mellon Corporation (NYSE: BK) reported third quarter 2020 earnings results today. Total revenue of $3.8 billion dipped less than 1% versus last year. Net income